問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberANT-006

2021-03-31 - 2027-06-30

Phase I

Terminated15

  • Trial Applicant

    COVANCE TAIWAN SERVICES LIMITED

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator Pei-Ying Pai

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 王志鴻

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 夏建勳

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Tsung-Hsien Lin

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Ping-Yen Liu

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 江承鴻

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 劉銘恩

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 曹玄明

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 林維祥

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Tze-Fan Chao

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Chun-Chieh Wang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 施志遠

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator JIN–LONG HUANG

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 黃奭毓

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Ming-Hsiung Hsieh

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    150 participants

  • Global

    1200 participants